Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel room-temperature synthesis method for phenolic compounds eliminates expensive catalysts, ensuring cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain continuity.
Novel Pd-catalyzed C-O coupling method for aryl esters. High yield up to 95%. Ideal for pharmaceutical intermediates. Cost-effective and scalable process.
Novel two-step route for o-alkynyl phenylcyclobutanone and naphthalenone synthesis offering high yield and scalability for pharma applications.
Novel Lewis acid catalyzed process for aromatic sulfinic acids reduces waste and energy. Reliable supply chain solution for pharmaceutical intermediate manufacturing partners.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Patent CN108503549A enables mild one-pot synthesis of aromatic trifluoroethyl esters. Delivers high purity, cost efficiency, and supply chain reliability for global pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-yield, high-ee synthesis of anticancer intermediates, ensuring cost-effective and reliable supply chain solutions.
Patent CN113620795B details a Rh-catalyzed C-H activation route to benzocycloheptenones. This method offers mild conditions, high yields, and scalable production for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-yield synthesis. Offers cost reduction and supply reliability for antitumor drug intermediates.
Patent CN114213424B reveals a cost-effective 3-step synthesis for furo[3,2-b]pyridine derivatives, offering high purity and scalable production for JAK1 inhibitor intermediates.
Novel synthesis method for axial chiral vinyl indolo compounds. High yield, mild conditions, suitable for pharmaceutical intermediates mass production and supply.
Patent CN102093292A reveals a safe two-step route for DL-alpha-aminocaprolactam, eliminating toxic azides for reliable pharmaceutical intermediates manufacturing.
Patent CN113387959B reveals a high-yield synthesis route for Parkinson's drug intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110452150B details a novel one-step synthesis of axial chiral indole-naphthalenes using chiral phosphoric acid, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high enantioselectivity. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN110452150A reveals high-purity axial chiral indole-naphthalene synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.
Novel isoindolinone-derived unsaturated imine synthesis via binaphthyl phosphoric acid. Delivers high yield, scalable production, and cost advantages for pharmaceutical supply chains.
Novel synthesis method offers high enantioselectivity and significant cost reduction for chiral catalyst manufacturing supply chains globally ensuring reliable pharmaceutical intermediates
Patent CN106366054B details non-metal catalytic coupling for ketone synthesis. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113620795B details a novel Rh-catalyzed route to benzocycloheptenones. Discover cost-effective API intermediate manufacturing with high scalability.